International Journal of Gynecological Cancer

Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies
pp. 591-599(9)
Authors: GOSWAMI,; RAJAPPA,; SHARMA,

Aromatase inhibitors in ovarian cancer: is there a role?
pp. 600-614(15)
Authors: LI,; HU,; FU,; LIU,; KAVANAGH,

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer
pp. 615-620(6)
Authors: GADDUCCI,; TANA,; TETI,; ZANCA,; FANUCCHI,; GENAZZANI,

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer
pp. 621-628(8)
Authors: ARITS,; STOOT,; BOTTERWECK,; ROUMEN,; VOOGD,

Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy
pp. 629-636(8)
Authors: BLAND,; EVERETT,; PASTORE,; ANDERSEN,; TAYLOR,

Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors
pp. 637-641(5)
Authors: JUNG,; CHOI,; JU,; KIM,

Characteristics of recurrence in adult-type granulosa cell tumor
pp. 642-647(6)
Authors: LEE,; PARK,; KIM,; SONG,; KANG,

Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction
pp. 648-651(4)
Authors: SIRISABYA,; LI,; JAISHUEN,; ZHENG,; GERSHENSON,; KAVANAGH,

Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma
pp. 652-659(8)
Authors: LIU,; CHEN,; HE,; FAN,; YANG,; LIN,; DU,; LI,; YE,; MAO,; ZHAO,; WEI,

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer
pp. 660-669(10)
Authors: DU,; SUN,; MILAM,; BODURKA,; FANG,

Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway
pp. 670-676(7)
Authors: LANE,; CARTIER,; RANCOURT,; PICHÉ,

Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I
pp. 677-691(15)
Authors: WEI,; CAO,; REN,; LIU,; YU,; LI,; HAO,

The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma
pp. 692-701(10)
Authors: PALMER,; SANT CASSIA,; IRWIN,; MORRIS,; ROLLASON,

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
pp. 702-710(9)
Authors: STEFFENSEN,; WALDSTRØM,; JEPPESEN,; BRANDSLUND,; JAKOBSEN,

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer
pp. 711-717(7)
Authors: PATTAMADILOK,; HUAPAI,; RATTANATANYONG,; VASURATTANA,; TRIRATANACHAT,; TRESUKOSOL,; MUTIRANGURA,

ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl
pp. 718-722(5)
Authors: XU,; CAI,; CHEN,; LI,; ZHANG,; SUN,; WAN,

Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB
pp. 723-729(7)
Authors: MORTIER,; STROOBANTS,; AMANT,; NEVEN,; VAN LIMBERGEN,; VERGOTE,

Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma
pp. 730-735(6)
Authors: DARUS,; CALLAHAN,; NGUYEN,; PASTORE,; SCHNEIDER,; RICE,; JAZAERI,

One-year follow-up of single-visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand
pp. 736-742(7)
Authors: CHUMWORATHAYI,; SRISUPUNDIT,; LUMBIGANON,; LIMPAPHAYOM,

The psychosocial impact of human papillomavirus testing in primary cervical screening—a study within a randomized trial
pp. 743-748(6)
Authors: KITCHENER,; FLETCHER,; ROBERTS,; WHEELER,; ALMONTE,; MAGUIRE,

Absence of epidermal growth factor receptor mutations in cervical cancer
pp. 749-754(6)
Authors: ARIAS-PULIDO,; JOSTE,; CHAVEZ,; MULLER,; DAI,; SMITH,; VERSCHRAEGEN,

Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer
pp. 755-760(6)
Authors: HUANG,; LI,; WU,

The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon
pp. 761-765(5)
Authors: TEBEU,; MAJOR,; RAPITI,; PETIGNAT,; BOUCHARDY,; SANDO,; deBERNIS,; ALI,; MHAWECH-FAUCEGLIA,

Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer
pp. 766-772(7)
Authors: FISCHEROVA,; CIBULA,; STENHOVA,; VONDRICHOVA,; CALDA,; ZIKAN,; FREITAG,; SLAMA,; DUNDR,; BELACEK,

Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study
pp. 773-778(6)
Authors: LOOK,; BLESSING,; MICHENER,; RUBIN,; RAMIREZ,

Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases
pp. 779-784(6)
Authors: CHENG,; CAI,; LI,; WU,; DING,; WANG,; ZANG,

Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions
pp. 785-789(5)
Authors: LATTARIO,; FURTADO,; FONSECA,; SILVEIRA,; doVAL,; ALMEIDA,; CARVALHO,

Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters
pp. 790-796(7)
Authors: KAPUCUOGLU,; BULBUL,; TULUNAY,; TEMEL,

Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population
pp. 797-802(6)
Authors: BERRETTA,; MERISIO,; MELPIGNANO,; ROLLA,; CECCARONI,; DE IORIS,; PATRELLI,; NARDELLI,

Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel—long-term follow-up
pp. 803-808(6)
Authors: SORBE,; ANDERSSON,; BOMAN,; ROSENBERG,; KALLING,

Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
pp. 809-812(4)
Authors: OZGUROGLU,; BILICI,; ILVAN,; TURNA,; ATALAY,; MANDEL,; ŞAHINLER, İ.

Does hysteroscopy affect prognosis in apparent early-stage endometrial cancer?
pp. 813-819(7)
Authors: BEN-ARIE,; TAMIR,; DUBNIK,; GEMER,; BEN SHUSHAN,; DGANI,; PEER,; BARNETT-GRINESS,; LAVIE,

Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
pp. 820-824(5)
Authors: KWON,; ABRAMS,; SUGIMOTO,; CAREY,

Prognostic factors for ovarian metastases from primary gastric cancer
pp. 825-832(8)
Authors: WANG,; SHI,; WU,; YANG,; ZHANG,; LIU,

Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors
pp. 833-837(5)
Authors: FISCHEROVA,; CIBULA,; DUNDR,; ZIKAN,; CALDA,; FREITAG,; SLAMA,

Small cell neuroendocrine carcinoma of the endometrium and laparoscopic staging: a clinicopathologic study of a case and a brief review of the literature
pp. 838-843(6)
Authors: BIGE,; SAATLI,; SECIL,; KOYUNCUOGLU,; SAYGILI,

Epithelioid trophoblastic tumor of paracervix and parametrium
pp. 843-846(4)
Authors: NOH,; LEE,; KO,; HWANG,; SON,

Desmoplastic small round cell tumor masquerading as advanced ovarian cancer
pp. 847-850(4)
Authors: BLAND,; SHAH,; PISCITELLI,; BENTLEY,; SECORD,

Pseudo-Meigs' syndrome caused by uterine smooth muscle tumor of uncertain malignant potential with low vascular endothelial growth factor expression
pp. 851-853(3)
Authors: HUANG,; LEE,; HSU,

Alveolar soft part sarcoma of the uterine cervix
pp. 853-856(4)
Authors: GITAU,; SHEPHERD,; HUGHES,; ORIOLOWO,; YIANNAKIS,

Astonishingly rapid growth of malignant cystosarcoma phyllodes tumor in a pregnant woman—a case report
pp. 856-859(4)
Authors: NEJC,; PASZ-WALCZAK,; PIEKARSKI,; PLUTA,; BILSKI,; SEK,; POTEMSKI,; DURCZYNSKI,; WRONSKI,; JEZIORSKI,

Placental site trophoblastic tumor with antecedent molar pregnancy in association with human immunodeficiency virus infection
pp. 860-861(2)
Author: MOODLEY,

Ureteroarterial fistulas after radical pelvic surgery: pathogenesis, diagnosis, and therapeutic modalities
pp. 862-867(6)
Authors: ESCOBAR,; HOWARD,; KELLY,; ROLAND,; GRENDYS,; DOSORETZ,; ORR,

Magnifying lenses assisted nerve-sparing radical hysterectomy and prevention of nerve plexus trauma
pp. 868-875(8)
Authors: MANTZARIS,; RODOLAKIS,; VLACHOS,; ATHANASIOU,; THEOCHARIS,; SOTIRIPOULOU,; ANTSAKLIS,

Letter
pp. 876-877(2)